Timing of breast cancer surgery within the menstrual cycle: Tumor proliferative activity, receptor status and short-term clinical outcome

A. Mangia, M. De Lena, A. Barletta, F. Marzullo, M. Attolico, B. Stea, S. Petroni, A. Labriola, G. Cellamare, G. Digiesi, R. Altieri, F. Schittulli, A. Paradiso

Research output: Contribution to journalArticle

Abstract

We verified the variations of primary tumour steroid receptor status and proliferative activity at different times and phases (follicular vs luteal) of the menstrual cycle and their relationship with short clinical outcome in a cohort of 248 N- breast cancer patients. Steroid receptor content (ER and PgR) was evaluated by DCC assay and proliferative activity by 3H-Thymidine autoradiographic assay (TLI). Median age was 44 years, 60% of tumors were T1, and cytohistological grade was G1-2 in 54% of cases. At surgery, 57% were in the luteal phase while 43% were in the follicular phase. No significant variations were found in mean TLI or ER and PgR characteristics of the primary tumors surgically treated in different periods of the menstrual cycle; however, the ER level resulted significantly higher in 4th with respect to the 3rd week of menstrual cycle, while PgR level was higher in PgR+ cases treated during the 3rd week. The number of relapses and disease- free survival curves after 36 months median follow-up did not differ significantly for patients treated in different periods of the menstrual cycle (12% and 9% of disease relapses in luteal and follicular phases; p=n.s.). We can conclude, therefore, that TLI, ER and PgR expressions could vary significantly during menstrual cycle only in certain specific tumor subgroups.

Original languageEnglish
Pages (from-to)317-323
Number of pages7
JournalJournal of Experimental and Clinical Cancer Research
Volume17
Issue number3
Publication statusPublished - Sep 1998

Keywords

  • Breast cancer
  • DNA status
  • Hormone receptors
  • Menstrual cycle
  • Proliferative activity

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Timing of breast cancer surgery within the menstrual cycle: Tumor proliferative activity, receptor status and short-term clinical outcome'. Together they form a unique fingerprint.

  • Cite this

    Mangia, A., De Lena, M., Barletta, A., Marzullo, F., Attolico, M., Stea, B., Petroni, S., Labriola, A., Cellamare, G., Digiesi, G., Altieri, R., Schittulli, F., & Paradiso, A. (1998). Timing of breast cancer surgery within the menstrual cycle: Tumor proliferative activity, receptor status and short-term clinical outcome. Journal of Experimental and Clinical Cancer Research, 17(3), 317-323.